NYMXF — NYMOX PHARMACEUTICAL CORP
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1018735 ·
Last close
$0.13
Market Cap
$12.29M
52W High
$0.17
52W Low
$0.03
ADV30
23,103
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | — | -788,000 | -857,000 | 654,000 | 74,000 | 7,429,000 |
| Sep 2024 | 0 | 0 | -653,000 | -716,000 | 624,000 | 41,000 | 6,920,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-717,000
Investing CF
$0
Financing CF
$750,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.01
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-212,474,000
Inventory
—
Receivables
$27,000
ST Investments
—
EBIT TTM
$-1,424,000
Pretax Income TTM
$-1,573,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | -4,283,000 | -4,492,000 | 654,000 | 7,429,000 | — | -2,601,000 |
| Dec 2023 | 0 | -8,350,000 | -8,844,000 | 627,000 | 3,800,000 | — | -4,057,000 |
| Dec 2022 | 0 | -6,652,000 | -6,576,000 | 1,625,000 | 2,107,000 | — | -5,205,000 |
| Dec 2021 | 0 | -12,504,000 | -12,537,000 | 1,443,000 | 1,949,000 | — | -9,820,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TRIB | TRINITY BIOTECH PLC | $13.10M | $0.65 | — |
| NOTV | Inotiv, Inc. | $9.30M | $0.27 | — |
| BMRA | BIOMERICA INC | $7.63M | $2.47 | — |
| AWHL | Aspira Women's Health Inc. | $19.79M | $0.46 | — |
| BIAF | bioAffinity Technologies, Inc. | $7.48M | $1.65 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.